Six new polyphenols with different isoprenylated xanthones, isoprenylated acylphloroglucinols, and chromone architectures, hyperfaberols A-F (1-6), were isolated from the whole plants of Hypericum faberi along with seven other related known compounds. In which hyperfaberols A/B (1/2) and 12-13 were isoprenylated xanthones, hyperfaberols C-E (3-5) and 8-11 were seven isoprenylated acylphloroglucinol derivatives, while 6-7 were two chromones. Their structures were elucidated by comprehensive analysis of their spectroscopic data as well as detailed comparison with the literature data. Compounds 1 and 11 showed cytotoxities against the human esophageal cancer cell line (ECA-109) and the pancreatic tumor cell line (PANC-1) in vitro, respectively. 
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Hypericum faberi R. Keller is distributed in the south and west of China [16] . Detailed literature research shows that it has never been phytochemical studied before. To further explore the new and bioactive natural polyphenols from Hypericum species, H. faberi was selected to carry out a phytochemical study and six new polyphenols, hyperfaberols A-F (1-6), together with additional seven known related derivatives 5,7-dihydroxy-2-isopropylchromon (7) [17] , madeleinol A (8) [18] , empetrifranzinans A/B (9/10) [18] , otogirin (11) [19] , dulxanthone D (12) [20] , and toxyloxanthone B (13) [21] were isolated. It's noteworthy that these isolates can be divided to three group based on their structural characters: isoprenylated xanthones (1-2 and 12-13), isoprenylated acylphloroglucinols (3-5 and 8-11), and chromones (6) (7) . In the bioactive assay, compounds 1 and 11 showed cytotoxities against the human esophageal cancer cell line (ECA-109) and the pancreatic tumor cell line (PANC-1) in vitro, respectively. Herein, we report the results of the isolates from the whole plant of H. faberi and their biological evaluation. 13 C NMR, which indicated a xanthone skeleton of 1 as hinted by the UV absorption bands at 203, 267 and 333 [22, 23] . In the HMBC spectrum, the correlations from 1-HO to C-1, C-2, C-9, and C-9a; from H-2 to C-1, C-3, C-4, C-9, and C-9a; from H-5 to C-6, C-7, C-8a, C-9, and C-10a, and from H 2 -11 to C-3, C-4, and C-4a confirmed the xanthone framework (Fig. 2) .
Results and Discussion
Carefully analysis of the 1D NMR spectra indicated the remianing 15 carbon signals (from C-11 to C-25) should assigned to three isoprenyl derived units. Two of which were deduced to form a lavandulyl moiety by the 1 H-1 H COSY cross-peaks of H 2 -11/H-12/H 2 -13/H-14 together with the HMBC correlations from H 2 -20 to C-12, C-18 and C-19, and from H 3 -16/H 3 -17 to C-14 and C-15. The location of this lavandulyl moiety at C-4 was evidenced by the HMBC correlations of H-11 with C-3, C-4, and C-4a [24] . The third isoprenyl group was elucidated to form a characteristic pyran ring between C-7 and C-8 as revealed by the HMBC correlations from H-21 to C-7, C-8, C-8a, and C-23, and from H 3 -24/H 3 -25 to C-7, C-22, and C-23. Consequently, the structure of 1, hypefaberol A, was established as shown ( Fig. 1) .
Hyperfaberol B (2), a yellow amorphous powder, had the molecular formula C 19 3 carbons (one methyl, one methoxy, one methylene, and one oxygenated methine). Side-by-side analysis of the 1 H and 13 C NMR spectra indicated that 2 were closely similar to the known xanthone, 2,3-dihydro-4-hydroxy-9-methoxy-2-(1-methylethenyl)-6H-furo [3,2-b] xanthen-5-one [25] . The only difference was that the aromatic proton (H-3) in the latter was replaced by a hydroxy group in 2, which can be confirmed by the downfiled chemical shift of 154.3 (C-3), the obvious HMBC correlations from the two ortho-coupled aromatic protons H-1/H-2 to C-3, from H-1 to C-9, C-9a, and C-4a, from H-2 to C-3, C-4, C-9, and C-9a, from H-5 to C-6, C-7, C-8a, C-9, and C-10a, from HO-8 to C-7, C-8, C-8a, and C-9, from H 2 -12 to C-6, C-7, and C-8, from H 2 -16 to C-13, C-14, and C-15, and the 1 H-1 H COSY between H 2 -12 and H-13. Thus, the structure of 2 was elucidated and named hyperfaberol B (Fig. 1 ).
Hyperfaberol C (3) was isolated as a yellow gum. The molecular formula was established as C 21 H 32 O 6 from its 13 C NMR (Table 3) 106.0, C-3; 162.2, C-4; 94.2, C-5; and 159.6, C-6), which indicated that 3 could be an acylphloroglucinol derivative. The location of the acyl group at C-1 was evidenced by the HMBC correlation of HO-2 with C-7 and further indicated the formation of intramolecular hydrogen bonding between the hydroxyl and the carbonyl group. In addition, the HMBC correlations from HO-2 to C-1, C-2, and C-3, from HO-4 to C-3, C-4, and C-5, and from HO-6 to C-1, C-5, and C-6 were all presented, which confirmed the phloroglucinol core furthermore. The remaining eleven signals was assigned to three methyls, one methoxy, three methylenes, two methines (including one sp 2 methine), and two quaternary carbons (including one sp 2 carbon). The 1 H-1 H COSY correlations of H 2 -11/H-12 and H 2 -15/ H 2 -16/H-17, conjugated with the HMBC correlations from H 3 -14 to C-12, C-13, and C-15, from H 3 -19/H 3 -20 to C-17 and C-18, and from H 3 -21 to C-18, established the 6-hydroxy-7-methoxy-3,7-dimethyl-2-octenyl partial structure for the fifteen signals moiety (Fig. 2) [26] . Moreover, the HMBC correlations from H 2 -11 to C-2, C-3 and (Table 3 ). The difference lied in that compound 3 has one more methoxy group than 4, meanwhile, the oxygenated quaternary carbon (δ C 76.8, C-18) and Me-20 (δ C 19.6) in 3 were also replaced by a terminal double bond (δ C 148.2, C-18; and 109.8, C-20) in 4, which could be confirmed by the 1 H-1 H COSY cross-peaks of H 2 -11/H-12 and H 2 -15/H 2 -16/H-17, and the HMBC correlations from H 3 -14 to C-12, C-13, and C-15, from H 2 -20 to C-17, C-18, and C-19, and from H 2 -11 to C-2, C-3, and C-4. In the ROESY spectrum, an NOE cross-peak between Me-14 and H 2 -11 was observed, indicating the E configuration of C-12/13 double bond of the moiety (Fig. 2) . Thus, the structure of 4 was therefore established to be that show in Fig. 1 .
Hyperfaberol E (5) gave the molecular formula of (Table 4) , which was confirmed by the 1 H-1 H COSY cross-peaks of H-8/H 3 -9/H 3 -10 and the HMBC correlations of Me-9/Me-10 to C-7 and C-8 (Fig. 2) .
Hyperfaberol F (6) was isolated as an amorphous powder. Its molecular formula of C 13 H 14 O 4 was assigned on the basis of its 13 carbonyl, six aromatic carbons, and two olefinic carbons) and four sp 3 carbons (two methyls, one methylene, and one methine) ( Table 5 ). The nine downfield sp 2 signals indicated that 6 possessed a chromone skeleton, while the four signals for sp 3 carbons relatively upfield confirmed the presence of the sec-butyl group observed in the 1 H NMR spectrum. The 1D NMR data of 6 was similar to those of 5, 7-dihydroxy-2-isopropylchromon (7) [17] , the difference lies in that the isopropyl in 7 was substituted by a sec-butyl group (δ C 39.4, C-9; 17.5, C-10; 26.9, C-11; and 11.4, C-12) in 6, which can be proved by the correlations from H-9 to C-2 in the HMBC spectrum, as well as the long linkage of H-9/H 3 -10/ H 2 -11/H 3 -12 in the 1 H-1 H COSY spectrum (Fig. 2) . Thus, the structrue of 6 was assigned as shown.
Empetrifranzinan A/B (9/10) have been previously described from Hypericum empetrifolium [18] . However, the relative configurations of the two compounds were not given in previous literature, and which are demonstrated herein. In the ROESY spectrum of 9, the NOE correlations of H-11/H12a, H-12a/H-15b/H-17, and H-12a/H 3 -14 suggested the β-orientation of H-11, Me-14, and H-17. The same relative configuration of 10 was also established as shown in Fig. 3 .
The inhibitory activities of the isolates were examined against the five human tumor cell lines (ECA-109, PANC-1, BIU-87, and BEL-7402) with taxol as the positive control (IC 50 values of 1.2, 3.5, 2.1 and 1.9 μM, respectively) [28] . Compound 1 showed cytotoxicity against the human esophageal cancer cell line (ECA-109) with an IC 50 value of 12.8 μM, while compound 11 exhibited activity against the pancreatic tumor cell line (PANC-1) with an IC 50 value of 12.0 μM. Additionally, other isolates showed no activities against the five human tumor cell lines with IC 50 values > 30 μM.
Experimental
General Experimental Procedures
Optical rotations were measured on a JASCO P-1020 polarimeter. UV spectra were recorded on a Shimadzu UV-2401PC spectrometer. IR spectra were recorded on a Bruker FT-IR Tensor-27 infrared spectrophotometer with KBr disks. 1D and 2D NMR spectra were recorded on a Bruker DRX-600 spectrometer using TMS as an internal standard. The chemical shifts (δ) were expressed in ppm with reference to the solvent signals. ESIMS and HR-ESIMS analysis were carried out on Waters Xevo TQS and Agilent G6230 TOF mass spectrometers, respectively. Preparative and semi-preparative HPLC were performed on Waters 1525 HPLC (column: SunFire OBD-C 18 , 19 × 250 mm) and Agilent 1100 HPLC (column: Zorbax SB-C 18 , 9.4 × 250 mm), respectively. Silica gel (100-200 and 200-300 mesh, Qingdao Marine Chemical Co., Ltd., People's Republic of China), and MCI gel (75-150 μm, Mitsubishi Chemical Corporation, Tokyo, Japan) were used for column chromatography. Fractions were monitored by TLC (GF 254, Qingdao Marine Chemical Co., Ltd.), and spots were visualized by heating silica gel plates immersed in H 2 SO 4 in ethanol.
Plant Material
The whole plants of H. faberi were collected in Yiliang County, Zhaotong City, Yunnan Province, China. It was identified by Dr. Yong-Zeng Zhang in Kunming Institute of Botany. A voucher specimen (no. 201707H01) has been deposited at the Kunming Institute of Botany.
Extraction and Isolation
The dried whole plants of H. faberi (15.0 kg) were powdered and percolated with MeOH at room temperature and filtered. The filtrate was evaporated in vacuo to be concentrated. The crude extract (3.2 kg) was subjected to a silica gel column chromatography (CC) using elution of successive CHCl 3 and EtOAc to give a non-polar fraction (163.0 g) and a polar fraction (192 g 
Cytotoxcity Assay
The cytotoxic assay with taxol as a positive control was conducted by MTT method in 96-well plates reported previously (Biological Assay, Supporting Information) [7] .
